Alessandro Noseda
Director/Board Member at REGENERX BIOPHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Alessandro Noseda is an Independent Director at RegeneRx Biopharmaceuticals, Inc. He is also a Director at Metheresis Translational Research SA, Thule Therapeutics SA, and Rostaquo.
Previously, he served as the Chief Medical Officer at Leadiant Biosciences, Inc. from 1998 to the present.
He also held the position of Chief Scientific Officer at Leadiant Biosciences SpA from 2007 to the present.
Prior to that, he was the Chief Executive Officer at Leadiant Biosciences SA from 2007 to 2017.
Dr. Noseda holds a doctorate degree from Wake Forest School of Medicine and the University of Milan, which he received in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Alessandro Noseda active positions
| Companies | Position | Start |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Director/Board Member | 2019-03-31 |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The private company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2018-08-31 |
| Thule Therapeutics SA | Director/Board Member | - |
| Rostaquo | Director/Board Member | - |
| Metheresis Translational Research SA | Director/Board Member | - |
Former positions of Alessandro Noseda
| Companies | Position | End |
|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Chief Executive Officer | 2016-12-31 |
Training of Alessandro Noseda
| Wake Forest School of Medicine | Doctorate Degree |
| University of Milan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
| Metheresis Translational Research SA | |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The private company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
| Thule Therapeutics SA | |
| Rostaquo |
- Stock Market
- Insiders
- Alessandro Noseda
